April 15, 2003- Lecture Notes Outline
Topics:
In Vitro Mutagenesis
Applications:
1. Determine the functional groups of a protein
2. Protein engineering- Enhance or modify enzymatic or protein function "Directed Evolution
Improve proteins with single amino acid changes - pharmocokinetics, structure stability bioavailability
Ex.- engineer insulin that are monomeric, absorb 2-3x efficiently
Ex. TPA- engineered to be resistant to oxidative stress
Ex.- improve enzymes- pH, oxidative, thermal and alkaline stability, substrate specificity,
SITE DIRECTED MUTAGENESIS
General Strategy (overview pdf)
1. Mutagenize plasmid DNA in vitro
2. Transform mutagenized plasmid DNA into competent cells
3. Screen for colonies that contain mutant plasmid DNA
Many approaches to mutagenize plasmid in vitro
Restriction Endonuclease sites provide the simplest access for mutagenesis (eliminate site pdf)
a. S1 nuclease removes single stranded nucleotides to leave a blunt end
b. DNA Polymerase + dNTPs added to fill-in
3. Blunt end ligation
4. Restriction Site is eliminated
Linker insertion mutagenesis (linker insertion)
Transposon Mutagenesis- Described Dr. Mike Cleary's lecture with Tn5 to screen for mutated plasmid
Construction of Nested Deletions
Bi-Directional (nested deletion mutagenesis)
Unidirectional Nested Deletion Mutatagenesis (uni-directional pdf)
Similar to bi-directional except use Exonuclease III to preferentially digest the 3/ end of a linear DNA molecule with 5' protuding nucleotides. Therefore, need to cleave with enzymes (such as Bam HI) which leaves a 5' overhang. After exonuclease II the remain single stranded tail can be removed with S1 nuclease.
Disadvantage: Need for unique restriction sites in desired regions
Synthetic Oligonucleotides
The Nobel Prize in Chemistry 1993
Kary B. Mullis Michael Smith"
for contributions to the developments of methods within DNA-based chemistry" "for his invention of the polymerase chain reaction (PCR) method" "for his fundamental contributions to the establishment of oligonucleotide-based, site-directed mutagenesis and its development for protein studies"1. Oligonucleotide-directed mutagenesis involves the incorporation of a mutant oligonucleotide into one strand of plasmid DNA.
2. After DNA replication of this heteroduplex plasmid, any progeny plasmids that arise by replication of the wild-type strand will be homozygous for the wild-type allele, and any plasmids that arise by replication of the mutant strand will be homozygous for the mutant allele.
3. The resulting population of plasmids contains both wild-type and mutant plasmids that may only differ by a single base-pair mutation in a sequence which lacks an easily assayed phenotype.
4. Furthermore, when introduced into cells the mismatch repair system often repairs the mutated base to the complementary base in the wild-type strand before it has a chance to replicate, so the mutant plasmids are underrepresented relative to the wild-type plasmids.
Improved methods of in vitro mutagenesis destroy the wild-type template strand of DNA and thus favor replication of the mutant strand
The dut ung method:
DNA template is grown in a dut ung mutant of E. coli.
The dut gene encodes dUTPase which degrades dUTP. (Therefore dUTP accumulates in dut strains & U sometimes take the place T during DNA replication).
The ung gene encodes uracil N-glycosylase which normally removes U from DNA.
dut ung mutant - U is occasionally incorporated into DNA and this error is not repaired- not mutagenic.
A mutagenic oligonucleotide is annealed to a ssDNA template
Add DNA polymerase, dNTPs but no dUTP,
Add Ligase to circularize - template has Us Mutant has T's
Transformed into an ung+ recipient cell.
The uracil N-glycosylase excises the U leaving apyrimidinic (AP) sites in the template strand.
Presence of AP sites makes the DNA strand biologically inactive because it cannot be replicated by DNA polymerase
The plasmid DNA is cut at the AP sites by specific endonucleases. Hence, when the dsDNA is introduced into the ung+ recipient , only the mutant strand will be replicated.
Note that the dut ung method provides an enrichment for the mutant plasmids, not a selection -- typically only about 50% of the resulting plasmids carry the mutation introduced on the oligonucleotide.
Use of Dpn I to select mutants (Stratagene products)
Variation by Sawona et al
Cassette Replacement (cassette pdf)
a. the mutant sequence
b. compatible directed ends
3. Ligate the cassette with the original plasmid and transform into competent cells.
Primer Design for In Vivo Mutagenesis- success is dependant on the primer
* Primers should be between 25 and 45 bases in length,
* (Tm) of the primers should be greater than or equal to 78 C.
For calculating Tm for primers intended to introduce insertions or deletions, N=primer length % are whole numbers
Tm = 81.5 + 0.41(%GC) -675/N - %mismatch
* The desired mutation (deletion or insertion) should be in the middle of the primer ~10-15 bases of correct sequence on both sides.
5' end needs a min. of 8-10 bp
3'end needs a good match to act as a stable primer, otherwise it is susceptible to exonucleolytic degradation. More frequent priming if 10-15 perfectly matched nucleotides are present
* Minimum GC content of 40% and should terminate in one or more C or G bases.
* Must be purified either by fast polynucleotide liquid chromatography (FPLC) or by polyacrylamide gel electrophoresis (PAGE). Failure to purify the primers results in a significant decrease in mutation efficiency.
* It is important to keep primer concentration in excess. Varying the amount of template while keeping the concentration of the primer constantly in excess.
Screening for Colonies transformed with mutant plasmid DNA
Using radiolabeled probes to detect bacterial colonies (colony screen1)
PCR screening (PCR screen)
Screening for DNA samples for the presence of a defined mutation can be efficiently done via PCR
Based on the observation that PCRs require the 3'terminal base of the oligo to be perfectly complementary to the DNA template.
Glisic & Alavantic (1996) Four primers required used to amplify target DNA under standard PCR conditions, products analyzed with agarose gel-electrophoresis. No need to mini-prep DNA, toothpick labeled colonies on plate in 20 µl TE, vortex and take 2 µl for PCR reaction.
Primer 1- forward- to amplify target region (+ control)
Primer 2- allele specific forward- test for mutant (experimental) Use for 2nd round of amplification
Primer 3- allele specific forward- test for wild-type Use for 2nd round of amplification
Primer 4- reverse to amplify target region (+ control) See Figure
SSCP- Single Strand Conformation Polymorphism (SSCP pdf)
1. Amplify target by PCR
2. Denature PCR product (heat or formamide, or NaOH) to make single stranded. Single stranded DNA duplex fold into complex 3D structures. Differnet sequences can affect mobility in a gel.
3. Electrophoresis of single stranded DNA through a gel at neutral pH- detect differences between mutant and wild-type strands of DNA.
Commercial Kits
Amersham- Sculptor IVM Mutagenesis kit & Unique Site Elimination (USE) elimination kit
BioRad- Muta-gene in vitro mut. Kit
CLONTECH- Transformer sitedirected mutageneis kit
Promega- Altersite II; Gene Editor; Interchange; Error Prone PCR
Stratagene- Quik Change; ExSite PCR-based; Chameleon DS site-directed mutagenesis kit
NEB- Code20kit
References
Sambrook et al. Molecular Cloning a laboratory manual; Volume II
Primrose, Twyman & Old 6th Edition Principles of Gene Manipulation
Recombinant DNA 2nd Edition Watson, Gilman, Witkowski Zoller